May 17, 2023 Comments Off on New patent for Incyte Corp drug PEMAZYRE Posted in: Patent Added Annual Drug Patent Expirations for PEMAZYRE Pemazyre is a drug marketed by Incyte Corp and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent for Incyte Corp drug PEMAZYRE appeared first on DrugPaten…
May 17, 2023 Comments Off on New patent for Slayback Pharma drug TESTOSTERONE CYPIONATE Posted in: Patent Added Annual Drug Patent Expirations for TESTOSTERONE+CYPIONATE Testosterone Cypionate is a drug marketed by Am Regent, Cipla, Hikma, Hikma Farmaceutica, Padagis Us, Rising, Sandoz Inc, Sun Pharm Inds Ltd, Watson Labs,…
The post New patent for Slayback Pharm…